SAN FRANCISCO — Oxervate was well-tolerated and effective at reducing corneal lesions among patients with neurotrophic keratopathy, according to a presentation at the American Academy of Ophthalmology annual meeting.
“Neurotrophic keratopathy (NK) is a rare and degenerative disease that can potentially lead to severe ocular complications if not treated appropriately,” Natalie A. Afshari, MD, chief of cornea and refractive surgery at the University of California San Diego’s Shiley Eye Institute, told Ocular Surgery News. “Previously, there were no FDA-approved
Uncategorized